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Introduction: Maintenance of adequate cerebral perfusion is essential to brain function and health, but the 
role of arterial shear stress in the regulation of cerebrovascular responses has not been definitively 
addressed. We hypothesized that, if shear stress is a key regulator of arterial dilation, then matched increases 
in shear induced by distinct physiological stimuli (hypercapnia vs exercise), would induce similar changes 
in dilation of the internal carotid [ICA] and vertebral [VA] arteries. 
Methods: Healthy male (n=10) participants attended the laboratory 3 times, during which they were asked 
to breathe a mild hypercapnic gas mixture (CO2:~4.5%CO2), or perform a submaximal cycling test (EX; 
60%HRreserve), or rest quietly (CTRL). Blood flow, diameter and shear rate were assessed in the ICA 
(BL;10, 20, 30mins, post) and VA (BL;15, 25mins, post) using duplex ultrasound. Middle cerebral artery 
blood flow velocity (MCAv) was maintained at 30% above baseline values by adjusting CO2 and exercise 
intensity. 
Results: During CO2 and EX, blood flow and shear rate through the ICA and VA were significantly 
elevated (p<0.001) compared to CTRL, but no differences existed between CO2 and EX. The change in 
ICA and VA diameter from baseline in response to CO2 (5.3±0.8 and 4.4±2.0%) and EX (4.7±0.7 and 
4.7±2.2%) were similar, but both were significantly elevated compared to CTRL condition (0.10±0.10 and 
-0.58±0.13 %,all p<0.001). 
Conclusion: This is the first study in humans to compare the vasodilator impact of distinct stimuli that 
increase cerebral artery shear stress in humans. Our findings indicate that matched levels of shear, 
irrespective of their driving stimulus, induce similar changes in extra-cranial arterial diameter. This study 
therefore suggests an important mechanistic role for the endothelium in regulating cerebral artery dilation 
in response to common physiological stimuli in vivo.  Interventions that enhance endothelial function may 





In conduit arteries such as the coronary,1 brachial,2 radial,3 and femoral,4,5 it is well established 
that intra-arterial shear stress regulates endothelium-dependent vasoreactivity and that episodic 
increases in shear can induce anti-atherogenic adaptation in paracrine transduction pathways, 
including the nitric oxide (NO)-dilator system. Shear-mediated stimulation of the endothelium 
is a key mechanism responsible for vasodilation through these conduit arteries in humans.6 
 
Exercise increases blood flow to the brain in humans.7 Traditionally, the explanation for this 
has been attributed to a combination of physiological stimuli, including changes in arterial 
blood gases, blood pressure and metabolism.8 Another possible mechanism involves changes 
in arterial shear stress and consequent endothelium-mediated dilation.9 Recently, we 
demonstrated vasodilation of extra-cranial feed arteries as a result of hypercapnia induced 
increases in brain blood flow and shear stress in vivo.10,11 However, the impact of shear stress 
on cerebrovascular responses during exercise has not previously been investigated. 
 
In the current study, we propose that shear stress is involved in regulating cerebrovascular 
function during exercise in humans. We therefore examined the impact of matched elevations 
in arterial shear stress, induced by distinct mechanisms (exercise vs hypercapnia), with the 





Ten healthy male participants (age, 25±6 years; weight, 74.14±7.03kg; height, 2.11±0.21m) 
were recruited for the study. All participants were non-smokers, with a BMI<30, free of 
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cardiovascular, respiratory, cerebrovascular, musculoskeletal and/or metabolic diseases. The 
study was approved by the University of Western Australia’s Human Research Ethics 
Committee. The participants were informed of all experimental procedures and associated risk. 
Participants provided written informed consent before the commencement of the study. 
 
Experimental design  
After inclusion, participants were tested at the Cardiovascular Research Laboratory on three 
occasions separated by >48hours at the same time of day. Each visit consisted of one of three 
randomly assigned interventional protocols (Control [CTRL], Hypercapnia [CO2], or Exercise 
[EX]). Subjects arrived after fasting for a minimum of 6 hrs, with 24 hr abstinence from 
alcohol, caffeine and vigorous exercise. Upon arrival, participants were instrumented and 
underwent a 10 min rest period in a semi-recumbent position. Baseline (BL) recordings of the 
primary outcome measures were then collected during a further 5-minute period of quiet rest. 
Following baseline measures, subjects participated in one of three interventions: 1) 30-minutes 
of hypercapnia (see below); 2) 30-minutes of exercise at 60% heart rate (HR) reserve; or 3) 30-
minutes of rest (control day). Cerebrovascular (transcranial Doppler and duplex vascular 
ultrasound) and cardiorespiratory assessments were collected throughout each condition. 
 
Experimental procedures 
Cerebrovascular assessments  
Non-invasive insonation via 2MHz transcranial Doppler ultrasound (TCD; Spencer 
Technologies, Seattle, WA) was used to assess blood flow velocity in the middle (MCAv) and 
posterior (PCAv) cerebral arteries. The cerebral arteries were identified and optimised 
according to their signal depth, waveform and velocities, according to previously published 
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guidelines.12 The MCAv and PCAv were continuously recorded at baseline, throughout the 
30-minutes of each intervention, and during post-intervention assessments. 
 
Blood velocity and diameter of the internal carotid artery (ICA) and vertebral (VA) arteries 
(VA) were measured using a 10-15MHz multi-frequency linear array vascular ultrasound 
(Terason T3200, Teratech, Burlington, MA).13  Whilst ICA recordings were captured at 10, 20 
and 30 minutes of the intervention, the VA recording were captured at 15 and 25 minutes of 
the intervention.  Baseline and post-intervention recordings (5–10 minutes post) were collected 
for both the ICA and VA. All of the ICA and VA recordings were screen captured and stored 
as video files for offline analysis.14  
 
Cardiorespiratory measurements 
All cardiorespiratory variables were sampled continuously throughout the protocol at 1000Hz 
via an analogue-to-digital converter (Powerlab, 16/30; ADInstruments, Colorado Springs, CO). 
Partial pressure of oxygen and carbon dioxide were assessed using a gas analyser 
(ADInstruments, Colorado Springs, CO), heart rate (HR) was measured by a 3-lead 
electrocardiogram (ECG; ADI bioamp ML132), and beat-to-beat blood pressure by finger 




Hypercapnia (CO2) condition 
Hypercapnia was used as a stimulus to elevate cerebral blood flow (CBF) and shear stress for 
30 minutes. Hypercapnia was achieved via breathing an air mixture (4.5% CO2, 21% O2, and 
balance N2) through a spirometer connected to a Douglas bag. The participants were seated in 
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a semi-recumbent position whilst hypercapnia was induced. Simultaneous assessment of 
intracranial velocity (measured by transcranial Doppler of the left MCA and right PCA) and 
beat-by-beat extracranial blood flow (measurement by Duplex ultrasonography of the ICA and 
VA) was assessed along with beat-to-beat arterial pressure (Finometer Pro, Amsterdam, 
Netherlands). Continuous monitoring of MCAv was used as an index of real-time change in 
cerebrovascular shear stress. If necessary, the concentration of inspired CO2 was altered (range 
3-6%) to achieve the desired increase in arterial shear stress (~30% above baseline). 
 
Exercise condition 
Participants cycled at submaximal intensity (~60% heart rate (HR) reserve = 100-120bpm) for 
30-minutes to maintain a steady increase in CBF measures throughout the exercise condition. 
As with the hypercapnia intervention, continuous intracranial blood velocity and extra-cranial 
blood flow were measured at the same time points during the intervention. The MCAv during 
the 30-minute intervention was closely monitored to ensure that an elevated CBF and shear 
stress was achieved (~30% above baseline, to match the CO2 condition).   
 
Control condition 
Participants sat in a semi-recumbent position for 30-minutes. Continuous intracranial blood 




Statistical and graphing analysis was performed using GraphPad PRISM 6.01 software 
(GraphPad Software, LaJolla, CA, USA). All parameters were compared within-subjects using 
2-way ANOVA repeated-measures.  Bonferroni-correction for multiple comparisons were used 
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for all post-hoc analysis.  Finally, a correlation was performed between the absolute change in 
arterial shear stress and diameter in the ICA and VA. Statistical significance was assumed at 




All cardiorespiratory and cerebrovascular values, for the anterior (ICA, MCA) and posterior 
(VA, PCA) cerebral arteries, are provided in tables 1 and 2. 
 
Cardiorespiratory measures 
No changes were observed for any of the cardiorespiratory measures assessed during the 30 
minute CTRL condition (Table 1 and 2).   
 
During the CO2 and EX, MAP increased (p<0.01), but returned toward baseline values post-
intervention (Tables 1 and 2). The magnitude of increase in MAP was similar between the CO2 
and EX conditions, except for the post-intervention timepoint (p<0.001). No change in MAP 
was observed throughout the CTRL condition, but both CO2 and EX MAP data were 
significantly elevated throughout the intervention period, relative to the CTRL trial (p<0.001). 
 
The CO2 and CTRL conditions did not elicit any changes in HR, whereas the EX condition 
was associated with elevated HR compared to baseline values and by comparison to the other 
conditions during the intervention period.  PETO2 and PETCO2 were elevated throughout the 
CO2
 intervention (p<0.001), compared to baseline values and also when compared to the CTRL 




Cerebrovascular measures  
No changes in either MCAv or PCAv were observed during CTRL. When all time points were 
considered, similar mean increases, from BL, were observed in response to CO2 (28.1±3.4 and 
23.3±2.8%) and EX (27.7±3.8 and 19.6 ± .3.0%) in the in MCAv and PCAv, respectively 
(p<0.001). All MCAv and PCAv values were greater during the EX and CO2 conditions 
relative to the CTRL data (Figure 1; p<0.001). 
 
In terms of duplex ultrasound data collected in both the ICA and VA, the EX and CO2 
conditions stimulated similar magnitudes of increase in blood flow, blood velocity and shear 
rate (p < 0.001), relative to baseline value. Furthermore, blood flow, velocity and SR data 
collected under the CO2 and EX conditions were elevated compared to the CTRL condition 
throughout the intervention period (Figure 1; p<0.001). 
 
No changes ICA or VA diameter were observed during CTRL. In contrast, ICA and VA 
diameters increased from baseline values during both CO2 and EX (Table 1; p<0.001).  The 
increases in diameter, in both arteries, were higher than the changes observed in the CTRL 
condition at all timepoints, except for the VA diameters 10 minutes post intervention.  
However, there were no differences in the changes in diameter observed when the CO2 and 




Our findings indicate that matched increases in cerebrovascular shear stress, irrespective of the 
eliciting stimulus (CO2 or EX), induce similar increases in extra-cranial artery diameter in 
humans. This study therefore provides novel evidence that arterial shear stress, alongside 
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changes in blood gases and pressure, is an important stimulus regulating extracranial cerebral 
conduit artery dilation in vivo. Given that repetitive episodic increases in shear stress 
beneficially impact arterial function and structure,6 our novel observation provides a 
mechanistic basis for linking exercise, physical activity and cerebrovascular health in humans. 
 
It is well established that endothelium-dependent mechanisms play a key role in shear stress 
mediated vasodilation of coronary and peripheral arteries in humans.1,3-5,15 These studies have 
established a role for paracrine hormones such as NO and prostacyclin in vasomotor regulation, 
for example, in response to exercise. However, few studies have addressed the impact of 
changes in arterial shear on human cerebral vasodilator function in vivo. In animals, classic 
studies have established that increases in flow and shear stress through isolated cerebral conduit 
arteries trigger endothelial-mediated vasodilation.16  Recently, Raignault et al.17 illustrated that 
the cerebrovascular endothelium optimally couples shear stress to eNOS-mediated dilation 
under physiological pulse pressures, in contrast to static flow conditions. This strongly infers 
that changes in cerebral arteries are responsive to a pulsatile environment and that shear stress 
sensitivity and consequent production of NO are optimised under in vivo conditions.17  It is 
also well established that carotid artery remodelling as a result of chronic changes in flow is 
dependent upon the presence of a functional endothelial layer,18 implicating shear- and NO-
mediated mechanisms in arterial structural adaptation. Collectively these findings, in animals, 
support a key role for shear-mediated endothelial-dependent dilation of extra- and intra-cranial 
cerebral conduit arteries. However, few studies have addressed the role of shear in regulating 
the cerebral vasculature in humans. 
 
Recently we characterised the timecourse and response of ICA dilation to changes in shear 
using duplex ultrasound with high temporal resolution edge-detection and wall-tracking in 
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healthy subjects.10 We concluded that, in response to a sustained hypercapnic stimulus (5-
mins), dilation of the ICA occurs subsequent to marked increases in intra-arterial blood flow 
and shear stress. In a subsequent experiment,11 a brief hypercapnic stimulus (30 secs) triggered 
similar ICA vasodilator response patterns to the sustained 5 min stimulus, despite the absence 
of simultaneous increases in end tidal CO2, implicating shear, rather than hyercapnia driven 
dilation. The current study advances these findings by illustrating that exercise, a shear eliciting 
stimulus which induces smaller changes in arterial blood gas concentrations, nonetheless 
increases extra-cranial artery dilation in humans. Our findings indicate that elevating shear 
during exercise, to a level that matches that associated with hypercapnia, elicits similar dilation 
of both the ICA and VA.   
 
This study is one of the few to have assessed extra-cranial artery responses to exercise in 
humans. Whilst some previous studies have assessed blood flow responses in the ICA during 
exercise,7,19,20 these have not specifically focused on changes in arterial diameter or shear 
stress.  Furthermore, no study, to date, has reported changes in ICA diameter or shear during a 
prolonged bout of exercise. We observed significant ICA dilation during exercise in all 
subjects. Our findings therefore raise the possibility that exercise-mediated and shear-driven 
increases in the bioavailability of endothelium-derived dilators such as NO may counteract 
other vasoactive pathways, such as the increase in sympathetic drive associated with some 
forms of exercise. Indeed, functional sympatholysis is a well-established phenomenon in 
skeletal muscle arterioles during exercise.21,22 Ultimately, vasomotor drive to vascular smooth 
muscle, in response to a stimulus as complex and integrative as exercise, will reflect the balance 
between dilator and constrictor mechanisms and our study supports a role in this regard for 




This is the first study that has assessed VA diameter and shear relationships during EX, CO2 
and CTRL conditions in humans. Our findings indicate that the vertebral arteries exhibit dilator 
responses which are similar to those observed in the ICA. Only two previous studies, to our 
knowledge, have recorded VA blood flows during exercise in humans, but these did not address 
changes observed in either diameter or shear.7,20 When considered in concert with our 
contemporaneous MCA and PCA observations, our ICA and VA data therefore indicate that 
cerebral shear and artery dilation occur in both the anterior and posterior cerebral circulation 
in response to both EX and CO2 in humans.  
 
An interesting minor finding of the present study relates to change in shear and artery diameter 
following the cessation of exercise. We continued data collection in the post-exercise period, 
at different time-points in the ICA (5 mins post) and VA (10 mins post). Dilation remained 
somewhat elevated 5 mins post-exercise, whereas it had returned to near resting baseline levels 
10-min post-exertion. These findings provide some insight into the timecourse of change in 
extra-cranial artery diameter following a relatively prolonged exercise stimulus.  
 
There are several limitations of the current experiment. We recruited and studied young male 
subjects. The impact of cyclical changes in sex hormones on shear-mediated cerebrovascular 
function and health would be an important follow up study in women. Although our findings 
suggest that exercise and hypercapnia elicited shear-mediated endothelial dependent dilation 
of the ICA and VA, we did not utilize a NO antagonist to address specific endothelial pathways. 
Future studies, particularly in animals, involving more invasive approaches, for example 
endothelial denudation and/or pharmacological blockade, would advance our understanding of 
the endothelial dependency of extra-cranial dilation. We think it unlikely that direct effects of 
the EX and CO2 conditions on extra-cranial diameter were the result of increases in blood 
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pressure, per se.  Increases in intra-arterial pressure, and associated transmural pressure, are 
typically associated with myogenic mediated vasoconstriction,23 whereas we observed dilation 
in all subjects under both conditions.  PETCO2 was somewhat elevated above baseline in EX 
condition and we are therefore unable to exclude the possibility that CO2 directly induces extra-
cranial dilation during exercise. Nonetheless, we are unaware of any experimental evidence 
indicating that this occurs in conduit arteries and, furthermore, we recently demonstrated that 
ICA dilation in the presence of elevated shear occurs in the absence of changes in PETCO2. 
Finally, we acknowledge that the limitations of TCD impair our ability to extrapolate our 
extracranial diameter responses to changes in shear stress, to intracranial changes that may 
have simultaneously occurred in the MCA and PCA.  However, the intention of our study was 
to focus on the ICA and VA responses, with intracranial measures collected primarily in order 
to confirm that matching of shear in each intervention was successful.   
 
Conclusion 
We have demonstrated, for the first time in humans, that matched increases in shear stress 
through the extra-cranial cerebral conduit arteries in response to distinct stimuli induce similar 
levels of vasodilation.  Our novel findings quantified vasodilator changes in both the anterior 
and posterior extra-cranial conduit arteries, suggesting an important mechanistic role for the 
endothelium in regulating cerebrovascular function in humans. Interventions that enhance 
endothelial function may mitigate age-related decline in cerebrovascular vasodilator function 
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Figure 1.  Middle (MCAv) and posterior (PCAv) cerebral blood flow velocity (Panels A & C), 
internal carotid (ICA) and vertebral (VA) artery Shear  (Panels B and D),  pre (BL) 
during (10,15, 25, 30 minutes, respectively) and POST (5 and 10 minutes respectively) 
of the control (CTRL), carbon dioxide (CO2) and exercise (EX) interventions. φ 
indicate differences between CO2 and CTRL (p<0.001); τ indicates differences 
between EX and CTRL (p<0.001).  
 
Figure 2. Changes in diameter in the internal carotid (ICA), and vertebral (VA) arteries during 
(10, 15, 20, 25 and 30 mins, respectively) as well as POST (5 and 10 min, respectively) 
control (CTRL) carbon dioxide (CO2) and exercise (EX) interventions. Straight line 





Table 1. Anterior cerebral blood flow and cardiorespiratory measurements during control (CTRL), carbon dioxide (CO2), 
and exercise (EX) interventions (n=10). 
  Time (min)  
Measure Condition BL 10 20 30 Post INT 
Mean SD Mean SD Mean SD Mean SD Mean SD  
MAP  (mmHg) 
CTRL 88 11 90 8 90 8 93 8 91 9 
** CO2 87 7.6 100*φ 10 104*φ 14 102*φ 14 96 11 
EX 82φ 11 102*φ 10 102*φ 9.5 100*φ 7.7 86*ѱ 15.8 
HR       (bpm) 
CTRL 64 7 64 9 67 7 67 7 63 7 
** CO2 66 8 70 9 74 9 70 7 63 7 
EX φѱ 70 8 115φѱ 11 115φѱ 7 118φѱ 7 80φѱ 11 
PetO2 (mmHg) 
CTRL 95.2 6.8 97.7 3.2 98.5 5 100.4 6.9 96 6.2 
** CO2 φ 97.4 5 128*φ 2.9 130*φ 1.9 130 *φ 2.3 96 7.8 
EX ѱ 95.2 6.5 96.6ѱ 7.8 95.8ѱ 7.6 96.0ѱ 7.8 96.8 4.1 
PetCO2 
(mmHg) 
CTRL 42.7 4 42.4 2.7 41.9 3.6 41.3 3.6 41.6 3.4 
** CO2 φ 42.3 3 46.9*φ 2.4 46.3*φ 2.3 46.2*φ 2.2 41.3 2.5 
EX 41.6 3.1 44.7* 4.9 44.7* 4.5 44.4φ 5.2 40.8 2.4 
QICA (ml.min-1) 
CTRL 297 24.8 289 20.8 278 21.4 278 24.4 264 24.1 
** CO2 262 18.8 368*φ 23.8 380*φ 30.5 354*φ 25.1 256 16.1 
EX 274 16.9 361*φ 19.7 368*φ 29.6 394*φ 26 282 24.1 
ICA Diam (mm) 
CTL 5.2 0.2 5.2 0.2 5.2 0.2 5.2 0.2 5.2 0.2 
** CO2 5.0 φ 0.1 5.3* 0.1 5.3* 0.1 5.4* φ 0.1 5.2 0.1 
EX 5.1 0.2 5.2 0.2 5.4* 0.2 5.4* φ 0.2 5.3 0.2 
ICA Vel (cm.s-1) 
CTRL 41.1 1.5 40.8 1.2 39.7 1.7 39.6 1.6 38.3 2.2 
** CO2 39 2.1 49.5*φ 2.8 49.7*φ 2.7 49.3*φ 2.5 36.9 1.4 
EX 38 1.6 47.5*φ 1.5 47.4*φ 2.3 49.8*φ 2.5 39.7 1.9 
ICA shear 
CTRL 316 11.3 314 12.1 305 14.2 304 12.9 294 16.6 
** CO2 309 15.5 372* 18.0 369*φ 17.4 362*φ 14.2 286 12.2 
EX 297 12.4 366* 14.6 354*φ 14.1 371*φ 18.0 298 17.0 
MCAv (cm.s-1) 
CTRL 66 3 66 3 65 3 63 3 63 3 
** CO2 64 6 83*φ 7 83*φ 7 82*φ 7 68 5 
EX 58 3 75*φ 4 75*φ 5 74*φ 5 60 3 
Time: * = different from BL; p < 0.05, COND:  φ = different from CTRL; ѱ = different from CO2; p < 0.01, INT: ** = 
significant COND x TIME interaction;  φ = different from CTRL; ѱ = different from CO2; p < 0.001 
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Table 2. Posterior cerebral blood flow measurements during Control (CTRL), carbon dioxide (CO2), and Exercise (EX) 
interventions (n=8) 
  Time (min)  
Measure Condition BL 15 25 Post Int 
Mean SD Mean SD Mean SD Mean SD  
MAP  
 (mmHg)  
CTRL 92 3 93 3 90 4 93 4 
** CO2 94 3 102 5 106*φ 6 98 5 
EX 87 4 102*φ 3 101*φ 3 88 4 
HR      
  (BPM)  
CTRL 63 2 65 3 65 3 64 3 
** CO2 64 2 69 3 72*φ 3 65 3 
EX ѱ 68 2 114*φѱ 2 118*φѱ 2 80*φѱ 3 
PetO2  
(mmHg) 
CTRL 97.5 2.4 104.7 5.3 100 1.4 99.3 1.3 
** CO2 φ 97.5 2.4 129.9*φ 0.8 130.3*φ 1.3 100.1 0.9 
EX φ ѱ 95.9 1.7 94.1 φѱ 3.0 96.0ѱ 2.2 97.9 1.6 
PetCO2  
(mmHg) 
CTRL 40.2 2.3 36.7 4.5 40.2 2.2 41 0.9 
** CO2 φ 41.3 1.3 46.4*φ 0.8 46.1*φ 1 41 0.9 
EXφ 41.4 1.1 45.7φ 1.9 44.5 1.5 40.1 1.1 
QVA 
 (ml.min-1) 
CTRL 113 20.6 111 21.6 103 19.7 103 17.9 
** CO2 100 13.1 141* 16.1 142* 20 95 12.9 
EX 90 16.1 140* 26.2 143* 26.1 87 12.3 
VA Diam  
(cm) 
CTL 3.9 0.1 3.9 0.2 3.9 0.2 3.9 0.1  
CO2 3.9φ 0.2 4.2φ 0.2 4.2*φ 0.2 4.0φ 0.1 ** 
EX 3.7φ ѱ 0.2 3.9*ѱ 0.2 4.1*ѱ 0.2 3.7φѱ 0.1  
VA Vel  
(cm.s-1) 
CTRL 27.7 3.3 27.3 3.3 25.5 2.9 24.4* 3 
** CO2 24.7 φ 1.9 31.6* φ 2.2 31.2* 2.2 23.4 2 
EX 24.7 φ 2.0 31.1* φ 2.6 31.5* 2.5 24.1 1.7 
VA shear 
CTRL 282 28 279 27 261 25 249* 26 
** CO2 251 φ 14 305*φ 19 297*φ 16 237 17 
EX 268 16 322*φ 20 316*φ 20 261 16 
PCAv  
(cm.s-1) 
CTRL 49 3 47 3 47 3 46 3 
** CO2 φ 51 4 63*φ 5 63*φ 4 52 4 
EX 48 4 58*φѱ 5 56*φѱ 4 45*ѱ 3 
Time: * = different from BL; p < 0.05, COND:  φ = different from CTRL; ѱ = different from CO2; p < 0.01, INT: ** = 
significant COND x TIME interaction;  φ = different from CTRL; ѱ = different from CO2; p < 0.001 
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